Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Van Cutsem

Showing results (161-170 of 499) with videos related to

Pageof 50
Sort By:
Neuroendocrinology|April 1, 2015
Impact of Previous Somatostatin Analogue Use on the Activity of Everolimus in Patients with Advanced Neuroendocrine Tumors: Analysis from the Phase III RADIANT-2 TrialLowell B Anthony, Marianne E Pavel, John D Hainsworth, et al.
Cancer Treatment Reviews|June 5, 2019
Optimizing the management of locally advanced pancreatic cancer with a focus on induction chemotherapy: Expert opinion based on a review of current evidenceThomas Seufferlein, Pascal Hammel, Jean Robert Delpero, et al.
British Journal of Cancer|April 1, 2016
Evaluation of Angiopoietin-2 as a biomarker in gastric cancer: results from the randomised phase III AVAGAST trialUlrich T Hacker, Laura Escalona-Espinosa, Nicola Consalvo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Phase II multi-institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated, advanced gastric, or gastroesophageal adenocarcinomaJaffer A Ajani, Miguel B Fodor, Sergei A Tjulandin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 26, 2017
Quantitative imaging outperforms molecular markers when predicting response to chemoradiotherapy for rectal cancerInes Joye, Annelies Debucquoy, Christophe M Deroose, et al.
European Journal of Cancer (Oxford, England : 1990)|August 28, 2012
Phase I dose-escalation study of intravenous aflibercept administered in combination with irinotecan, 5-fluorouracil and leucovorin in patients with advanced solid tumoursEric Van Cutsem, David Khayat, Chris Verslype, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2012
Identification of a poor-prognosis BRAF-mutant-like population of patients with colon cancerVlad Popovici, Eva Budinska, Sabine Tejpar, et al.
European Journal of Cancer (Oxford, England : 1990)|August 11, 2024
Treating cancer-associated venous thromboembolism: A practical approachEric Van Cutsem, Isabelle Mahé, Enriqueta Felip, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 9, 2019
Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastasesRaphaëla Carmen Dresen, Sofie De Vuysere, Frederik De Keyzer, et al.
Expert Review of Gastroenterology & Hepatology|March 2, 2012
Management of advanced gastric cancerTimothy J Price, Jeremy D Shapiro, Eva Segelov, et al.
Pageof 50

Showing results (161-170 of 499) with videos related to

Sort By:
Pageof 50
Neuroendocrinology|April 1, 2015
Impact of Previous Somatostatin Analogue Use on the Activity of Everolimus in Patients with Advanced Neuroendocrine Tumors: Analysis from the Phase III RADIANT-2 TrialLowell B Anthony, Marianne E Pavel, John D Hainsworth, et al.
Cancer Treatment Reviews|June 5, 2019
Optimizing the management of locally advanced pancreatic cancer with a focus on induction chemotherapy: Expert opinion based on a review of current evidenceThomas Seufferlein, Pascal Hammel, Jean Robert Delpero, et al.
British Journal of Cancer|April 1, 2016
Evaluation of Angiopoietin-2 as a biomarker in gastric cancer: results from the randomised phase III AVAGAST trialUlrich T Hacker, Laura Escalona-Espinosa, Nicola Consalvo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Phase II multi-institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated, advanced gastric, or gastroesophageal adenocarcinomaJaffer A Ajani, Miguel B Fodor, Sergei A Tjulandin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 26, 2017
Quantitative imaging outperforms molecular markers when predicting response to chemoradiotherapy for rectal cancerInes Joye, Annelies Debucquoy, Christophe M Deroose, et al.
European Journal of Cancer (Oxford, England : 1990)|August 28, 2012
Phase I dose-escalation study of intravenous aflibercept administered in combination with irinotecan, 5-fluorouracil and leucovorin in patients with advanced solid tumoursEric Van Cutsem, David Khayat, Chris Verslype, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2012
Identification of a poor-prognosis BRAF-mutant-like population of patients with colon cancerVlad Popovici, Eva Budinska, Sabine Tejpar, et al.
European Journal of Cancer (Oxford, England : 1990)|August 11, 2024
Treating cancer-associated venous thromboembolism: A practical approachEric Van Cutsem, Isabelle Mahé, Enriqueta Felip, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 9, 2019
Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastasesRaphaëla Carmen Dresen, Sofie De Vuysere, Frederik De Keyzer, et al.
Expert Review of Gastroenterology & Hepatology|March 2, 2012
Management of advanced gastric cancerTimothy J Price, Jeremy D Shapiro, Eva Segelov, et al.
Pageof 50